Nuclear FAK and Runx1 cooperate to regulate IGFBP3, cell-cycle progression, and tumor growth

44Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Nuclear focal adhesion kinase (FAK) is a potentially important regulator of gene expression in cancer, impacting both cellular function and the composition of the surrounding tumor microenvironment. Here, we report in a murine model of skin squamous cell carcinoma (SCC) that nuclear FAK regulates Runx1-dependent transcription of insulin-like growth factor binding protein 3 (IGFBP3), and that this regulates SCC cell-cycle progression and tumor growth in vivo. Furthermore, we identified a novel molecular complex between FAK and Runx1 in the nucleus of SCC cells and showed that FAK interacted with a number of Runx1-regulatory proteins, including Sin3a and other epige-netic modifiers known to alter Runx1 transcriptional function through posttranslational modification. These findings provide important new insights into the role of FAK as a scaffolding protein in molecular complexes that regulate gene transcription.

Cite

CITATION STYLE

APA

Canel, M., Byron, A., Sims, A. H., Cartier, J., Patel, H., Frame, M. C., … Serrels, A. (2017). Nuclear FAK and Runx1 cooperate to regulate IGFBP3, cell-cycle progression, and tumor growth. Cancer Research, 77(19), 5301–5312. https://doi.org/10.1158/0008-5472.CAN-17-0418

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free